Proteus is devoted exclusively to research, characterization, collection, purification and packaging of neosaxitoxin. It complies with "cGMP's for Phase 1 Investigational drugs" of the U.S. FDA (conditioning Q2-2010).
A micro algae research-driven biotechnology company.
To explore the full potential of the active principle obtained from a specific micro-algae, improving patients’ quality of life by developing a variety of products and applications complying with national and international standards to market them globally.
Company Details
- Employees
- 3
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- neolanest.com
Proteus S.a. Questions
Proteus S.A.'s website is neolanest.com
Proteus S.A.'s LinkedIn profile is https://cl.linkedin.com/company/proteus-s.a.
Proteus S.A. has
3 employees.
View email and phone details for 3
employees at Proteus S.A..
Proteus S.A.'s industry is
Biotechnology Research
Proteus S.A.'s top competitors are
Gsp-Chile,
Essity,
Tractebel,
Dulcono Roma,
Proteus Digital Health, Inc,
Cascada Expediciones & Ecocamp Patagonia,
Almex Group,
Bd,
Andesmets.
Proteus S.A.'s categories are Biotechnology Research
Proteus S.A.'s founding year is 2007
